Market is slowly waking up to the growth potential of this little gem.
clinical backing stands this apart from a normal consumer product and it’s clear from the increasing sales in the US and now Italy, it’s a product that is moving. If they get something done in China, it’s off.
If you need product validation, Global pharma GSK paid the company $10m cash for the Indian Licence.
Will be interesting to watch play out.
Market is slowly waking up to the growth potential of this...
Add NGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.005M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $400 | 100K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2560243 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 327974 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.4¢ |
Change
0.000 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.4¢ | 0.4¢ | 100000 | ||
| Last updated 11.02am 03/05/2024 ? | |||||
| NGS (ASX) Chart |